title

DTB podcast

BMJ Group

1
Followers
0
Plays
DTB podcast
DTB podcast

DTB podcast

BMJ Group

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Drug and Therapeutics Bulletin Podcast

Latest Episodes

June 2019: If the drugs don’t work

In June's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the European Medicines Agency's decision to amend the licence for omega-3 fatty acid medicines so that they will no longer be authorised for secondary prevention after myocardial infarction. The editors also review ospemifene, a new medicine for the management of vulvar and vaginal atrophy and discuss a case of delusional infestation in the treatment of ADHD with atomoxetine. Read the full issue: https://dtb.bmj.com/content/57/6.

9 MINMAY 29
Comments
June 2019: If the drugs don’t work

May 2019: The new GP contract - an opportunity for drugs and therapeutics

In May's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the opportunities for drugs and therapeutics in the new GP contract for England. The editors also talk about the management of chronic cough and discuss a case of acute liver failure associated with a short course of nitrofuantoin. Read the issue online: https://dtb.bmj.com/content/57/5.

8 MINMAY 15
Comments
May 2019: The new GP contract - an opportunity for drugs and therapeutics

April 2019: DOAC dosing in renal impairment

In April's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the challenges of prescribing direct acting oral anticoagulant (DOAC) drugs for people with renal impairment. The editors also talk about the use of saline nasal irrigation and discuss central sensitisation syndrome. Read the issue online: https://dtb.bmj.com/content/57/4.

10 MINMAR 20
Comments
April 2019: DOAC dosing in renal impairment

Latest Episodes

June 2019: If the drugs don’t work

In June's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the European Medicines Agency's decision to amend the licence for omega-3 fatty acid medicines so that they will no longer be authorised for secondary prevention after myocardial infarction. The editors also review ospemifene, a new medicine for the management of vulvar and vaginal atrophy and discuss a case of delusional infestation in the treatment of ADHD with atomoxetine. Read the full issue: https://dtb.bmj.com/content/57/6.

9 MINMAY 29
Comments
June 2019: If the drugs don’t work

May 2019: The new GP contract - an opportunity for drugs and therapeutics

In May's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the opportunities for drugs and therapeutics in the new GP contract for England. The editors also talk about the management of chronic cough and discuss a case of acute liver failure associated with a short course of nitrofuantoin. Read the issue online: https://dtb.bmj.com/content/57/5.

8 MINMAY 15
Comments
May 2019: The new GP contract - an opportunity for drugs and therapeutics

April 2019: DOAC dosing in renal impairment

In April's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the challenges of prescribing direct acting oral anticoagulant (DOAC) drugs for people with renal impairment. The editors also talk about the use of saline nasal irrigation and discuss central sensitisation syndrome. Read the issue online: https://dtb.bmj.com/content/57/4.

10 MINMAR 20
Comments
April 2019: DOAC dosing in renal impairment

Listen Now On Himalaya